{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:20:08Z","timestamp":1788542408532,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11095-026-04132-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:44:20Z","timestamp":1783439060000},"page":"2211-2228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osmolyte-Based Formulations for Enhanced Thermal Stability of mRNA Drug Substance: A Systematic Screening and Optimization Study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-1554","authenticated-orcid":false,"given":"Anandi","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rita","family":"Silva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-4244","authenticated-orcid":false,"given":"Anurag S.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"1","key":"4132_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12929-023-00977-5","volume":"30","author":"YS Wang","year":"2023","unstructured":"Wang YS, Kumari M, Chen GH, Hong MH, Yuan JPY, Tsai JL, et al. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications. J Biomed Sci. 2023;30(1):84. https:\/\/doi.org\/10.1186\/s12929-023-00977-5.","journal-title":"J Biomed Sci"},{"key":"4132_CR2","unstructured":"National Center for Immunization and Respiratory Diseases (US). Updated (2023\u20132024 formula) Pfizer-BioNTech COVID-19 vaccine storage and beyond-use date tracking labels [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2025 Aug 19]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/134199."},{"key":"4132_CR3","unstructured":"Centers for Disease Control and Prevention (US). Moderna COVID-19 vaccines: vaccine preparation and administration summary [Internet]. Centers for Disease Control and Prevention; 2022 [cited 2025 Aug 19]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/123055."},{"issue":"2","key":"4132_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","volume":"112","author":"EO Blenke","year":"2023","unstructured":"Blenke EO, \u00d6rnskov E, Sch\u00f6neich C, Nilsson GA, Volkin DB, Mastrobattista E, et al. The storage and in-use stability of mRNA vaccines and therapeutics: not a cold case. J Pharm Sci. 2023;112(2):386\u2013403. https:\/\/doi.org\/10.1016\/j.xphs.2022.11.001.","journal-title":"J Pharm Sci."},{"issue":"3","key":"4132_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","volume":"110","author":"DJA Crommelin","year":"2021","unstructured":"Crommelin DJA, Anchordoquy TJ, Volkin DB, Jiskoot W, Mastrobattista E. Addressing the cold reality of mRNA vaccine stability. J Pharm Sci. 2021;110(3):997\u20131001. https:\/\/doi.org\/10.1016\/j.xphs.2020.12.006.","journal-title":"J Pharm Sci."},{"issue":"10","key":"4132_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/vaccines12101148","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, et al. Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines (Basel). 2024;12(10):1148. https:\/\/doi.org\/10.3390\/vaccines12101148.","journal-title":"Vaccines (Basel)."},{"key":"4132_CR7","unstructured":"Research C for DE and FDA [Internet]. FDA; 2024 [cited 2024 Nov 2]. Drug approvals and databases. Available from: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-approvals-and-databases. Accessed 2 Nov 2024."},{"issue":"5","key":"4132_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2144\/000112593","volume":"43","author":"KL Jones","year":"2007","unstructured":"Jones KL, Drane D, Gowans EJ. Long-term storage of DNA-free RNA for use in vaccine studies. Biotechniques. 2007;43(5):675\u201381.","journal-title":"Biotechniques."},{"issue":"12","key":"4132_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006108","volume":"11","author":"L Stitz","year":"2017","unstructured":"Stitz L, Vogel A, Schnee M, Voss D, Rauch S, Mutzke T, et al. A thermostable messenger RNA based vaccine against rabies. PLoS Negl Trop Dis. 2017;11(12):e0006108. https:\/\/doi.org\/10.1371\/journal.pntd.0006108.","journal-title":"PLoS Negl Trop Dis."},{"key":"4132_CR10","doi-asserted-by":"publisher","unstructured":"Sreenivasan S, Rathore AS. Taurine, a Naturally Occurring Amino Acid, as a Physical Stability Enhancer of Different Monoclonal Antibodies. AAPS J. 2024;26(1):25. https:\/\/doi.org\/10.1208\/s12248-024-00893-y.","DOI":"10.1208\/s12248-024-00893-y"},{"key":"4132_CR11","unstructured":"Ketterer T, Mutzke T, Wiggenhorn M, Schaubhut F, M\u00fcLBE FVD. Lyophilization of RNA [Internet]. WO2016165831A1, 2016 [cited 2024 Nov 4]. Available from: https:\/\/patents.google.com\/patent\/WO2016165831A1\/en. Accessed 4 Nov 2024."},{"issue":"1","key":"4132_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"RM Lu","year":"2024","unstructured":"Lu RM, Hsu HE, Perez SJLP, Kumari M, Chen GH, Hong MH, et al. Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci. 2024;31(1):89. https:\/\/doi.org\/10.1186\/s12929-024-01080-z.","journal-title":"J Biomed Sci."},{"issue":"1_Supplement","key":"4132_CR13","doi-asserted-by":"publisher","first-page":"223.22","DOI":"10.4049\/jimmunol.210.Supp.223.22","volume":"210","author":"SH Bae","year":"2023","unstructured":"Bae SH, Bang EK, Lim BK, Lee J, Yoo S, Park HJ, et al. Trehalose-based lipid improves mRNA vaccine safety. J Immunol. 2023;210(1_Supplement):223.22. https:\/\/doi.org\/10.4049\/jimmunol.210.Supp.223.22.","journal-title":"J Immunol"},{"issue":"2","key":"4132_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/21645515.2018.1526585","volume":"15","author":"T Hasan","year":"2018","unstructured":"Hasan T, Kumari K, Devi SC, Handa J, Rehman T, Ansari NA, et al. Osmolytes in vaccine production, flocculation and storage: a critical review. Hum Vaccin Immunother. 2018;15(2):514\u201325. https:\/\/doi.org\/10.1080\/21645515.2018.1526585.","journal-title":"Hum Vaccin Immunother."},{"issue":"4","key":"4132_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/07373937.2022.2103564","volume":"41","author":"DT Osanl\u00f3o","year":"2023","unstructured":"Osanl\u00f3o DT, Fransson J, Bergenst\u00e5hl B, Millqvist-Fureby A. Effects of drying methods on physical properties and morphology of trehalose\/mannitol mixtures. Dry Technol. 2023;41(4):503\u201322. https:\/\/doi.org\/10.1080\/07373937.2022.2103564.","journal-title":"Dry Technol."},{"issue":"1","key":"4132_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bpc.2011.05.012","volume":"159","author":"M Auton","year":"2011","unstructured":"Auton M, R\u00f6sgen J, Sinev M, Holthauzen LMF, Bolen DW. Osmolyte effects on protein stability and solubility: a balancing act between backbone and side-chains. Biophys Chem. 2011;159(1):90\u20139. https:\/\/doi.org\/10.1016\/j.bpc.2011.05.012.","journal-title":"Biophys Chem."},{"key":"4132_CR17","doi-asserted-by":"publisher","unstructured":"Arns L, Schuabb V, Meichsner S, Berghaus M, Winter R. The effect of natural osmolyte mixtures on the temperature-pressure stability of the protein RNase A. Zeitschrift f\u00fcr Physikalische Chemie. 2018;232(5\u20136):615\u201334. https:\/\/doi.org\/10.1515\/zpch-2017-1039.","DOI":"10.1515\/zpch-2017-1039"},{"issue":"3","key":"4132_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/v15030668","volume":"15","author":"F Cheng","year":"2023","unstructured":"Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research advances on the stability of mRNA vaccines. Viruses. 2023;15(3):3. https:\/\/doi.org\/10.3390\/v15030668.","journal-title":"Viruses."},{"issue":"1","key":"4132_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","volume":"8","author":"L Zhang","year":"2023","unstructured":"Zhang L, More KR, Ojha A, Jackson CB, Quinlan BD, Li H, et al. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. NPJ Vaccines. 2023;8(1):156. https:\/\/doi.org\/10.1038\/s41541-023-00751-6.","journal-title":"NPJ Vaccines."},{"issue":"1","key":"4132_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MCO.0b013e328341235a","volume":"14","author":"SS Yarandi","year":"2011","unstructured":"Yarandi SS, Zhao VM, Hebbar G, Ziegler TR. Amino acid composition in parenteral nutrition: what is the evidence? Curr Opin Clin Nutr Metab Care. 2011;14(1):75\u201382. https:\/\/doi.org\/10.1097\/MCO.0b013e328341235a.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"4132_CR21","doi-asserted-by":"publisher","unstructured":"Wang SS, Yan YS, Ho K. US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives. Antib Ther. 2021;4(4):262\u201372. https:\/\/doi.org\/10.1093\/abt\/tbab027.","DOI":"10.1093\/abt\/tbab027"},{"key":"4132_CR22","unstructured":"Drugs@FDA: FDA-Approved Drugs [Internet]. [cited 2025 Sep 4]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm. Accessed 4 Sept 2024."},{"key":"4132_CR23","volume-title":"GRAS notice no. GRN 000912: trehalose [Internet]","author":"N Pasecinic","year":"2020","unstructured":"Pasecinic N, Pen & Tec Consulting S.L.U., on behalf of c-LEcta GmbH, editor. GRAS notice no. GRN 000912: trehalose [Internet]. US Food and Drug Administration, Center for Food Safety and Applied Nutrition; 2020. Available from: https:\/\/www.fda.gov\/media\/153916\/download."},{"key":"4132_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/IJN.S123062","volume":"12","author":"RL Ball","year":"2016","unstructured":"Ball RL, Bajaj P, Whitehead KA. Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization. Int J Nanomed. 2016;12:305. https:\/\/doi.org\/10.2147\/IJN.S123062.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4132_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bioactmat.2020.03.001","volume":"5","author":"P Zhao","year":"2020","unstructured":"Zhao P, Hou X, Yan J, Du S, Xue Y, Li W, et al. Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioact Mater. 2020;5(2):358\u201363. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.03.001.","journal-title":"Bioact Mater"},{"key":"4132_CR26","unstructured":"Maximizing mRNA vaccine production with Bayesian optimization - Rosa - 2022 - Biotechnology and Bioengineering - Wiley Online Library [Internet]. [cited 2026 Jan 20]. Available from: https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bit.28216."},{"issue":"5","key":"4132_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jmb.2007.03.080","volume":"370","author":"D Lambert","year":"2007","unstructured":"Lambert D, Draper DE. Effects of osmolytes on RNA secondary and tertiary structure stabilities and RNAMg2+ ion interactions. J Mol Biol. 2007;370(5):993. https:\/\/doi.org\/10.1016\/j.jmb.2007.03.080.","journal-title":"J Mol Biol"},{"issue":"234","key":"4132_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123662","volume":"15","author":"S Khan","year":"2023","unstructured":"Khan S, Siraj S, Shahid M, Haque MM, Islam A. Osmolytes: Wonder molecules to combat protein misfolding against stress conditions. Int J Biol Macromol. 2023;15(234):123662. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123662.","journal-title":"Int J Biol Macromol."},{"issue":"13","key":"4132_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.addr.2011.06.011","volume":"63","author":"S Ohtake","year":"2011","unstructured":"Ohtake S, Kita Y, Arakawa T. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 2011;63(13):1053\u201373. https:\/\/doi.org\/10.1016\/j.addr.2011.06.011.","journal-title":"Adv Drug Deliv Rev."},{"key":"4132_CR30","unstructured":"Talley C. Process for lyophilized pharmaceutical formulation of a therapeutic protein [Internet]. EP3681483B1, 2022 [cited 2025 Aug 28]. Available from: https:\/\/patents.google.com\/patent\/EP3681483B1\/en. Accessed 28 Aug 2025."},{"issue":"12","key":"4132_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13205-022-03370-5","volume":"12","author":"Z Ma","year":"2022","unstructured":"Ma Z, Wu C, Zhu L, Chang R, Ma W, Deng Y, et al. Bioactivity profiling of the extremolyte ectoine as a promising protectant and its heterologous production. 3 Biotech. 2022;12(12):331. https:\/\/doi.org\/10.1007\/s13205-022-03370-5.","journal-title":"3 Biotech"},{"issue":"1","key":"4132_CR32","doi-asserted-by":"publisher","first-page":"31434","DOI":"10.1038\/srep31434","volume":"6","author":"G Zaccai","year":"2016","unstructured":"Zaccai G, Bagyan I, Combet J, Cuello GJ, Dem\u00e9 B, Fichou Y, et al. Neutrons describe ectoine effects on water H-bonding and hydration around a soluble protein and a cell membrane. Sci Rep. 2016;6(1):31434. https:\/\/doi.org\/10.1038\/srep31434.","journal-title":"Sci Rep."},{"issue":"1","key":"4132_CR33","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1038\/s41467-024-50774-3","volume":"15","author":"IV Kuzmin","year":"2024","unstructured":"Kuzmin IV, Soto Acosta R, Pruitt L, Wasdin PT, Kedarinath K, Hernandez KR, et al. Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine. Nat Commun. 2024;15(1):6421. https:\/\/doi.org\/10.1038\/s41467-024-50774-3.","journal-title":"Nat Commun."},{"key":"4132_CR34","doi-asserted-by":"publisher","unstructured":"Murray A, Kilbride P, Gibson MI. Trehalose in cryopreservation. Applications, mechanisms and intracellular delivery opportunities. RSC Med Chem. 15(9):2980\u201395.\u00a0https:\/\/doi.org\/10.1039\/d4md00174e.","DOI":"10.1039\/d4md00174e"},{"key":"4132_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bioactmat.2024.05.012","volume":"38","author":"SH Bae","year":"2024","unstructured":"Bae SH, Yoo S, Lee J, Park HJ, Kwon SP, Jin H, et al. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety. Bioact Mater. 2024;38:486\u201398. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.012.","journal-title":"Bioact Mater."},{"issue":"8","key":"4132_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41589-024-01568-7","volume":"20","author":"M Pepelnjak","year":"2024","unstructured":"Pepelnjak M, Velten B, N\u00e4pflin N, von Rosen T, Palmiero UC, Ko JH, et al. In situ analysis of osmolyte mechanisms of proteome thermal stabilization. Nat Chem Biol. 2024;20(8):1053\u201365. https:\/\/doi.org\/10.1038\/s41589-024-01568-7.","journal-title":"Nat Chem Biol."},{"key":"4132_CR37","unstructured":"Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in AzoleResistant Candida albicans | Antimicrobial Agents and Chemotherapy [Internet]. [cited 2025 Aug 13]. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/aac.01106-07."},{"issue":"5","key":"4132_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1128\/MCB.01279-10","volume":"31","author":"CM Dewey","year":"2011","unstructured":"Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P, Good SK, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol. 2011;31(5):1098\u2013108. https:\/\/doi.org\/10.1128\/MCB.01279-10.","journal-title":"Mol Cell Biol."},{"key":"4132_CR39","doi-asserted-by":"publisher","unstructured":"Marathe S, Chougule H, Nikam V, Majumdar A, Bose T. Polyol sugar osmolyte - sorbitol corrects chromosome cohesion and translational defects in cohesin mutants [Internet]. bioRxiv; 2024 [cited 2025 Aug 13]. p. 2024.09.04.610945. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.09.04.610945v3, https:\/\/doi.org\/10.1101\/2024.09.04.610945.","DOI":"10.1101\/2024.09.04.610945"},{"issue":"1","key":"4132_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2023.10.008","volume":"49","author":"R Rodell","year":"2024","unstructured":"Rodell R, Robalin N, Martinez NM. Why U matters: detection and functions of pseudouridine modifications in mRNAs. Trends Biochem Sci. 2024;49(1):12\u20137. https:\/\/doi.org\/10.1016\/j.tibs.2023.10.008.","journal-title":"Trends Biochem Sci."},{"key":"4132_CR41","doi-asserted-by":"publisher","unstructured":"M\u00fcller UF, Tor Y. Citric Acid and the RNA World. Angew Chem Int Ed Engl. 2014;53(21):5245\u20137. https:\/\/doi.org\/10.1002\/anie.201400847.","DOI":"10.1002\/anie.201400847"},{"key":"4132_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124696","volume":"665","author":"H Athaydes Seabra Ferreira","year":"2024","unstructured":"Athaydes Seabra Ferreira H, Ricardo Aluotto Scalzo J\u00fanior S, Kelton Santos de Faria K, Henrique Costa Silva G, T\u00fallio Rodrigues Alves M, Oliveira Lobo A, et al. Cryoprotectant optimization for enhanced stability and transfection efficiency of pDNA-loaded ionizable lipid nanoparticles. Int J Pharm. 2024;665:124696. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124696.","journal-title":"Int J Pharm"},{"issue":"3","key":"4132_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1051\/lait:2003010","volume":"83","author":"AS Carvalho","year":"2003","unstructured":"Carvalho AS, Silva J, Ho P, Teixeira P, Malcata FX, Gibbs P. Protective effect of sorbitol and monosodium glutamate during storage of freeze-dried lactic acid bacteria. Lait. 2003;83(3):203\u201310. https:\/\/doi.org\/10.1051\/lait:2003010.","journal-title":"Lait."},{"issue":"4","key":"4132_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0264-410X(90)90091-Y","volume":"8","author":"S Ishizaka","year":"1990","unstructured":"Ishizaka S, Yoshikawa M, Kitagami K, Tsujii T. Oral adjuvants for viral vaccines in humans. Vaccine. 1990;8(4):337\u201341. https:\/\/doi.org\/10.1016\/0264-410X(90)90091-Y.","journal-title":"Vaccine."},{"issue":"1","key":"4132_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/pro.5560060123","volume":"6","author":"G Xie","year":"1997","unstructured":"Xie G, Timasheff SN. Mechanism of the stabilization of ribonuclease A by sorbitol: preferential hydration is greater for the denatured then for the native protein. Protein Sci. 1997;6(1):211\u201321. https:\/\/doi.org\/10.1002\/pro.5560060123.","journal-title":"Protein Sci."},{"issue":"36","key":"4132_CR46","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1021\/jp981119l","volume":"102","author":"JK Kaushik","year":"1998","unstructured":"Kaushik JK, Bhat R. Thermal stability of proteins in aqueous polyol solutions: role of the surface tension of water in the stabilizing effect of polyols. J Phys Chem B. 1998;102(36):7058\u201366. https:\/\/doi.org\/10.1021\/jp981119l.","journal-title":"J Phys Chem B."},{"issue":"18","key":"4132_CR47","doi-asserted-by":"publisher","first-page":"2203022","DOI":"10.1002\/adhm.202203022","volume":"12","author":"KN Kafetzis","year":"2023","unstructured":"Kafetzis KN, Papalamprou N, McNulty E, Thong KX, Sato Y, Mironov A, et al. The effect of cryoprotectants and storage conditions on the transfection efficiency, stability, and safety of lipid-based nanoparticles for mRNA and DNA delivery. Adv Healthc Mater. 2023;12(18):2203022. https:\/\/doi.org\/10.1002\/adhm.202203022.","journal-title":"Adv Healthc Mater."},{"key":"4132_CR48","doi-asserted-by":"publisher","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586.","DOI":"10.1016\/j.ijpharm.2021.120586"},{"issue":"198","key":"4132_CR49","doi-asserted-by":"publisher","DOI":"10.3791\/65200","volume":"18","author":"AT Karl","year":"2023","unstructured":"Karl AT, Essex S, Wisnowski J, Rushing H. A workflow for lipid nanoparticle (LNP) formulation optimization using designed mixture-process experiments and self-validated ensemble models (SVEM). J Vis Exp (JoVE). 2023;18(198):e65200. https:\/\/doi.org\/10.3791\/65200.","journal-title":"J Vis Exp (JoVE)."},{"key":"4132_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41541-023-00732-9","volume":"8","author":"M Li","year":"2023","unstructured":"Li M, Jia L, Xie Y, Ma W, Yan Z, Liu F, et al. Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine. NPJ Vaccines. 2023;8:153. https:\/\/doi.org\/10.1038\/s41541-023-00732-9.","journal-title":"NPJ Vaccines."},{"key":"4132_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125272","volume":"671","author":"A Ruppl","year":"2025","unstructured":"Ruppl A, Kiesewetter D, K\u00f6ll-Weber M, Lemazurier T, S\u00fcss R, Allmendinger A. Formulation screening of lyophilized mRNA-lipid nanoparticles. Int J Pharm. 2025;671:125272. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125272.","journal-title":"Int J Pharm."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04132-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:08:17Z","timestamp":1788541697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4132"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04132-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}